Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bispecific Estrogen Receptor α Degraders Incorporating Novel Binders Identified Using DNA-Encoded Chemical Library Screening
Jeremy S. Disch, Jennifer M. Duffy, Esther C. Y. Lee, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 8, pp. 5049-5066
Closed Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

PROTACs: past, present and future
Ke Li, Craig M. Crews
Chemical Society Reviews (2022) Vol. 51, Iss. 12, pp. 5214-5236
Open Access | Times Cited: 426
Protein degraders enter the clinic — a new approach to cancer therapy
Deborah Chirnomas, Keith R. Hornberger, Craig M. Crews
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 4, pp. 265-278
Closed Access | Times Cited: 343
PROTACs: great opportunities for academia and industry (an update from 2020 to 2021)
Ming He, Chao-Guo Cao, Zhihao Ni, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 174
Chemistries of bifunctional PROTAC degraders
Chao-Guo Cao, Ming He, Liguo Wang, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 16, pp. 7066-7114
Closed Access | Times Cited: 170
DNA-encoded chemical libraries
Alexander L. Satz, Andreas Brunschweiger, Mark E. Flanagan, et al.
Nature Reviews Methods Primers (2022) Vol. 2, Iss. 1
Closed Access | Times Cited: 125
Discovery of small molecule ligands for the von Hippel-Lindau (VHL) E3 ligase and their use as inhibitors and PROTAC degraders
Claudia J. Diehl, Alessio Ciulli
Chemical Society Reviews (2022) Vol. 51, Iss. 19, pp. 8216-8257
Open Access | Times Cited: 124
Small-molecule discovery through DNA-encoded libraries
Alexander A. Peterson, David R. Liu
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 9, pp. 699-722
Closed Access | Times Cited: 93
Strategies for developing DNA-encoded libraries beyond binding assays
Yiran Huang, Yizhou Li, Xiaoyu Li
Nature Chemistry (2022) Vol. 14, Iss. 2, pp. 129-140
Closed Access | Times Cited: 86
Targeted protein degradation: advances in drug discovery and clinical practice
Guangcai Zhong, Xiaoyu Chang, Weilin Xie, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 19
Degraders upgraded: the rise of PROTACs in hematological malignancies
Joshua Casan, John F. Seymour
Blood (2024) Vol. 143, Iss. 13, pp. 1218-1230
Closed Access | Times Cited: 16
A bibliometric analysis of PROTAC from 2001 to 2021
Deping Li, Dongmin Yu, Yan Li, et al.
European Journal of Medicinal Chemistry (2022) Vol. 244, pp. 114838-114838
Closed Access | Times Cited: 66
Fluorinated Cycloalkyl Building Blocks for Drug Discovery
Oleksandr O. Grygorenko, Kostiantyn P. Melnykov, Serhii Holovach, et al.
ChemMedChem (2022) Vol. 17, Iss. 21
Closed Access | Times Cited: 57
Click chemistry and drug delivery: A bird's-eye view
Shameer M. Kondengadan, Shubham Bansal, Ce Yang, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 5, pp. 1990-2016
Open Access | Times Cited: 50
DNA-Encoded Library Screening To Inform Design of a Ribonuclease Targeting Chimera (RiboTAC)
Samantha M. Meyer, Toru Tanaka, Patrick R. A. Zanon, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 46, pp. 21096-21102
Closed Access | Times Cited: 43
Optimization of PROTAC Ternary Complex Using DNA Encoded Library Approach
Qiuxia Chen, Chuan Liu, Wei Wang, et al.
ACS Chemical Biology (2023) Vol. 18, Iss. 1, pp. 25-33
Open Access | Times Cited: 29
PROTACs: A novel strategy for cancer drug discovery and development
Xin Han, Yi Sun
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 25
Unlocking the potential of PROTACs: A comprehensive review of protein degradation strategies in disease therapy
Ritesh P. Bhole, Payal R. Kute, Rupesh V. Chikhale, et al.
Bioorganic Chemistry (2023) Vol. 139, pp. 106720-106720
Closed Access | Times Cited: 23
Metabolism-driven in vitro/in vivo disconnect of an oral ERɑ VHL-PROTAC
Thomas G. Hayhow, Beth Williamson, Mandy Lawson, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 11
Innovative, combinatorial and high-throughput approaches to degrader synthesis
Rebecca Stevens, James D. F. Thompson, Julie C. L. Fournier, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 10, pp. 4838-4861
Closed Access | Times Cited: 9
Recent advances in IAP-based PROTACs (SNIPERs) as potential therapeutic agents
Chao Wang, Yujing Zhang, Lingyu Shi, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 1437-1453
Open Access | Times Cited: 29
Discovery of ERD-3111 as a Potent and Orally Efficacious Estrogen Receptor PROTAC Degrader with Strong Antitumor Activity
Zhixiang Chen, Biao Hu, Rohan Kalyan Rej, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 17, pp. 12559-12585
Open Access | Times Cited: 21
Molecular glue degraders: exciting opportunities for novel drug discovery
Thomas Lemaître, Marie Cornu, Florian Schwalen, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 4, pp. 433-449
Closed Access | Times Cited: 8
Breaking Bad Proteins—Discovery Approaches and the Road to Clinic for Degraders
Corentin Bouvier, Rachel Lawrence, Francesca Cavallo, et al.
Cells (2024) Vol. 13, Iss. 7, pp. 578-578
Open Access | Times Cited: 7
Discovery of novel nitrofuran PROTAC-like compounds as dual inhibitors and degraders targeting STING
Liang Xue, Ruixue Liu, Lican Zhang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116883-116883
Closed Access | Times Cited: 6
VHL-based PROTACs as potential therapeutic agents: Recent progress and perspectives
Chao Wang, Yujing Zhang, Jie Wang, et al.
European Journal of Medicinal Chemistry (2021) Vol. 227, pp. 113906-113906
Closed Access | Times Cited: 41
Page 1 - Next Page

Scroll to top